Epitalon: the four-residue pineal peptide, and what the lab data shows

Epitalon, also written epithalon, is a synthetic linear tetrapeptide with the sequence Ala-Glu-Asp-Gly. It came out of the Khavinson bioregulator program in St Petersburg, a decades-long Russian research effort that set out to reduce complex tissue extracts to the shortest peptide fragment that still carried a measurable signal. Epitalon is the short-peptide analogue modelled on epithalamin, a preparation made from the pineal gland. Its whole design philosophy is minimalism: four amino acids, no caps, no unusual residues, just the smallest string the group could associate with pineal and neuroendocrine activity in their models.

The bioregulator idea

The bioregulator concept deserves a plain explanation, because it frames everything published on the compound. Vladimir Khavinson and colleagues argued that many tissue extracts owe their activity to very short peptides, and that these peptides behave less like classical hormones and more like signals that influence which genes a cell reads. Epitalon sits alongside other members of that family, short peptides such as the dipeptide vilon and the tripeptide pinealon, each associated with a different tissue.

The pineal association is why epitalon is usually discussed in the context of circadian and neuroendocrine regulation, since the pineal gland is the source of melatonin and a node in circadian timekeeping. Framing it this way also sets expectations: a four-residue peptide is not a hormone with a dedicated receptor, so the mechanisms proposed for it are transcriptional rather than classical signalling.

The proposed mechanism

The mechanistic claim most associated with epitalon is an effect on telomerase, the enzyme that extends the repetitive DNA at chromosome ends. In cultured human somatic cells, research from the Khavinson group reported increased telomerase activity and longer telomeres after exposure to the peptide. The proposed model is transcriptional: the tetrapeptide is small enough to enter the nucleus and is thought to interact with DNA or DNA-associated proteins in a sequence-specific way, nudging expression of genes including the telomerase catalytic subunit. That is a striking mechanism to claim for a four-residue peptide, and it is exactly the kind of result that needs independent replication before it can be relied on.

One point often blurred in secondary sources is worth pinning down: epitalon is not melatonin, and it is not a melatonin precursor. It is a distinct synthetic peptide whose association with the pineal gland is by way of the epithalamin extract it was modelled on, not by any shared chemistry with the melatonin pathway. The proposed link to circadian biology runs through gene expression, with some reports describing restored melatonin rhythm in aged animals after exposure, rather than through the peptide supplying melatonin itself. Keeping that separation clear avoids a common misreading of the aging literature.

A second strand of proposed mechanism concerns gene regulation more broadly. The Khavinson model holds that short peptides bind particular DNA motifs and modulate the readout of nearby genes, effectively acting as tiny transcriptional signals. For epitalon the genes of interest cluster around pineal function and antioxidant defence. Molecular-modelling and binding studies in that literature try to show how so small a molecule could recognise a DNA sequence, though the structural evidence remains thinner than the functional readouts.

The chemistry, spelled out

On identity, epitalon is unambiguous. The sequence is Ala-Glu-Asp-Gly, the molecular formula is C14H22N4O9, the molecular weight is about 390.35 g/mol, and the CAS number is 307297-39-8. It is a linear peptide built entirely from standard L-amino acids with free N- and C-termini, which is why it can be represented cleanly as a four-letter sequence. Note the trap that catches many buyers: an N-acetyl epitalon exists as a separate molecule, and its amide and free-acid forms differ again, so identity should always be confirmed against the sequence and mass rather than the name alone.

What the literature examines

The published record has a distinctive shape. Much of it originates from a single research tradition, which is both a strength (internal consistency, long follow-up in animal colonies) and a weakness (limited independent replication). The main areas examined are telomerase and telomere length in cell culture; markers of aging and lifespan in rodent colonies, where long-running Anisimov and Khavinson studies tracked spontaneous tumour incidence and survival; and pineal and neuroendocrine gene expression, including effects on melatonin rhythm in aged animals. More recent overview articles gather this body of work and try to place it in the wider aging-research literature.

For anyone characterising the peptide in the lab, the practical notes are simple. Because the sequence is short and includes acidic residues, epitalon is water soluble and easy to reconstitute, but it is also easy to degrade through repeated freeze-thaw. Confirming purity by reversed-phase HPLC and mass by spectrometry is the norm, particularly to rule out the acetylated variants that share a similar name. As with any bioregulator claim, the cleanest experiments separate the specific tetrapeptide signal from generic amino-acid effects by including scrambled-sequence and vehicle controls.

Honest limitations

The caveats are substantial. The great majority of the primary data comes from one group and its collaborators, and large parts were published in Russian-language journals that saw limited independent scrutiny. Telomerase activation by a free tetrapeptide is not a widely reproduced finding outside that tradition, and the structural account of how such a small peptide selects a DNA sequence is incomplete. Animal-model lifespan work is suggestive but does not transfer across species without direct testing. In short, epitalon is an interesting and much-cited research peptide whose most dramatic claims rest on a narrow evidentiary base. Read the mechanistic literature as a set of hypotheses under investigation, not settled fact.

For laboratory research use only. Not for human or veterinary use.

Verified molecule

• Research names: epitalon, epithalon
• Sequence: Ala-Glu-Asp-Gly (AEDG)
• Class: synthetic linear tetrapeptide; Khavinson bioregulator
• Molecular formula: C14H22N4O9
• Molecular weight: 390.35 g/mol
• CAS number: 307297-39-8

Common questions

What is epitalon derived from?

It is a synthetic tetrapeptide modelled on epithalamin, a pineal-gland preparation studied in the Khavinson bioregulator program. Epitalon reduces that complex extract to a defined four-residue sequence, Ala-Glu-Asp-Gly.

Why is epitalon linked to telomerase in research?

Studies from the group that developed it reported increased telomerase activity and longer telomeres in cultured human somatic cells. The proposed model is that the small peptide enters the nucleus and influences expression of the telomerase catalytic subunit. This finding needs broader independent replication.

Is epitalon the same as N-acetyl epitalon?

No. N-acetyl epitalon carries an added acetyl group and exists in distinct amide and free-acid forms, each a different molecule with a different mass. Always confirm identity by sequence and molecular weight, not by name.

References

1. Khavinson VKh, Bondarev IE, Butyugov AA. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bulletin of Experimental Biology and Medicine, 2003.
2. Anisimov VN, Khavinson VKh, Popovich IG, Zabezhinski MA, et al. Effect of epitalon on biomarkers of aging, life span and spontaneous tumour incidence in mice. Biogerontology, 2003.